Stock Market

Does This Biopharma Company’s “Pipeline In A Drug” Cancer Therapy Make Its Stock A Buy?

The clinical-stage biopharmaceutical company discussed in today’s article, which is focused on developing innovative cancer therapies.

COVID case numbers are surging again thanks the Delta variant, and concerns that this will result in more lockdowns and travel restrictions may be part… Read More »The “Delta Scare” Could Be A Great Opportunity To Get In On “The Explosive Small-Cap Energy” Story

With the fast-spreading Delta variant of the coronavirus taking hold in the U.S. and many countries around the world, we may just be entering the… Read More »As We Enter The Second Inning Of The Pandemic, Could This “Dark Horse” COVID Vaccine Stock Win The Long Game?

“With the more contagious delta variant now dominant in the U.S. despite the widespread availability of vaccines, the need for effective treatments is once again… Read More »An Effective Oral Therapy For COVID-19 Could Make This Under-The-Radar Biopharma Company A Big Winner

“Cancer treatments have remained a hotbed for biotech companies.”

The company’s drug for wet AMD had proven to help with the disorder, and thus it seems highly likely it will be approved.

“It was a difficult first half for biotech stocks, once again underscoring how conditions may seem so ideal but investment returns can still be hard… Read More »Why The Coming Months Could Be A “Biotech Bonanza”

“Wall Street analysts following these biotechs have high expectations for the drugs they’re developing and in one case already marketing.

If you feel like biotech stocks tend to go down right after you buy them, you’re not alone – and today’s article provides some important… Read More »Why Your Biotech Buys Keep Going Down – And How To Solve The Problem

New stocks to watch in 2021.